Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qishen capsule plus atorvastatin versus atorvastatin alone for chest pain with carotid atherosclerosis
ChiCTR-IIR-17013393Phase 4Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of qishen capsule and atorvastatin in atherosclerosis, dyslipidemia and angina pectoris (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoints: Carotid plaque and Symptom score of traditional Chinese medicine. Started Nov 2017; status: recruiting.
02
Drugs
qishen capsuleatorvastatin
03
Conditions
atherosclerosisdyslipidemiaangina pectoris
Beyond the preview
Go deeper on ChiCTR-IIR-17013393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17013393.